Pharmacologic suppression of MITF expression via HDAC inhibitors in the melanocyte lineage

Keyphrases

• Pharmacologic 100%
• Histone Deacetylase Inhibitor (HDACi) 100%
• Melanocyte Lineage 100%
• Microphthalmia-associated Transcription Factor 100%
• Melanoma Cells 40%
• Inhibitor Drug 40%
• Clear Cell Sarcoma 40%
• Drug Target 20%
• Targeting Strategies 20%
• Clinical Setting 20%
• Melanoma 20%
• Anti-melanoma 20%
• Cellular Targets 20%
• Human Melanoma 20%
• Oncogene 20%
• Systemic Therapy 20%
• Catalytic Activity 20%
• Therapeutic Role 20%
• Small Molecule Inhibitors 20%
• Skin pigmentation 20%
• Drug Application 20%
• Melanocytes 20%
• Sarcoma Cells 20%
• Alternative Drugs 20%
• Oncogenic Role 20%
• Drug Evidence 20%
• Topical Therapy 20%
• Mouse Xenograft 20%
• Melanoma Incidence 20%
• Restricted Mechanisms 20%

Medicine and Dentistry

• Histone Deacetylase Inhibitor 100%
• Melanocyte 100%
• Microphthalmia Associated Transcription Factor 100%
• Melanoma 80%
• Clear-Cell Sarcoma 40%
• In Vitro 20%
• Xenograft 20%
• Carcinogenesis 20%
• Melanoma Cell 20%
• Oncogene 20%
• Systemic Therapy 20%
• Drug Delivery System 20%
• Sarcoma Cell 20%
• Play Therapy 20%
• Topical Agent 20%
• Skin Pigmentation 20%